The DOI matches its Crossref record; 765 of the 770 references it cites were found in a registry or an index.
The epigenetics of aging and neurodegeneration
Open accessAbstract
Epigenetics is a quickly growing field encompassing mechanisms regulating gene expression that do not involve changes in the genotype. Epigenetics is of increasing relevance to neuroscience, with epigenetic mechanisms being implicated in brain development and neuronal differentiation, as well as in more dynamic processes related to cognition. Epigenetic regulation covers multiple levels of gene expression; from direct modifications of the DNA and histone tails, regulating the level of transcription, to interactions with messenger RNAs, regulating the level of translation. Importantly, epigenetic dysregulation currently garners much attention as a pivotal player in aging and age-related neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, where it may mediate interactions between genetic and environmental risk factors, or directly interact with disease-specific pathological factors. We review current knowledge about the major epigenetic mechanisms, including DNA methylation and DNA demethylation, chromatin remodeling and non-coding RNAs, as well as the involvement of these mechanisms in normal aging and in the pathophysiology of the most common neurodegenerative diseases. Additionally, we examine the current state of epigenetics-based therapeutic strategies for these diseases, which either aim to restore the epigenetic homeostasis or skew it to a favorable direction to counter disease pathology. Finally, methodological challenges of epigenetic investigations and future perspectives are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, the cellular heterogeneity of the AD brain presents significant analytical hurdles. Advanced computational deconvolution techniques or experimental methods such as fluorescence-activated cell sorting (FACS) are often required to resolve distinct cell populations, including neurons, astrocytes, and microglia127,157.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10
Dönmez, G., Wang, D., Cohen, D. E., & Guarente, L. (2010) · Cell · doi:10.1016/j.cell.2010.06.020 · Cited by 443
RetractedLiang, Q., Fujita, R., Yamashita, T., Angulo, S. L., Rhinn, H., Rhee, D. B., Doege, C. A., Chau, L., Aubry, L., Vanti, W. B., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.007 · Cited by 231
RetractedKAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling
Kaidi, A., & Jackson, S. P. (2013) · Nature · doi:10.1038/nature12201 · Cited by 167
RetractedKuhn, D. E., Nuovo, G. J., Terry, A. V., Martin, M. M., Malana, G. E., Sansom, S. E., Pleister, A. P., Beck, W. D., Head, E., Feldman, D. S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033407 · Cited by 121
RetractedInitial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Research works printed but not linked: 2
- Alarcón, 2004, Chromatin acetylation, memory, and LTP are impaired in CBP+/− mice: a model for the cognitive deficit in Rubinstein–Taybi syndrome and its amelioration, Neuron, 42, 947, 10.1016/j.neuron.2004.05.021 · DOI · Paper page
- Lovestone, 1997, The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes, Neuroscience, 78, 309
Cited by
Sorted by citations
How neuroinflammation contributes to neurodegeneration
Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967
Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
Tiwari, S., Atluri, V., Kaushik, A., Yndart, A., & Nair, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200490 · Cited by 1,308
Predicting Age Using Neuroimaging: Innovative Brain Ageing Biomarkers
Cole, J. H., & Franke, K. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.10.001 · Cited by 939
β-Hydroxybutyrate: A Signaling Metabolite
Newman, J. C., & Verdin, E. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064916 · Cited by 872
“The broader role of epigenetics in cognition and neurodegenerative disease has been reviewed (67, 68, 100).”
Šimić, G., Leko, M. B., Wray, S., Harrington, C. R., Delalle, I., Milošević, N. J., Bažadona, D., Buée, L., de Silva, R., Giovanni, G. D., et al. (2016) · Biomolecules · doi:10.3390/biom6010006 · Cited by 730
Self-citationMolecular genetics of early-onset Alzheimer’s disease revisited
Cacace, R., Sleegers, K., & Van Broeckhoven, C. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.01.012 · Cited by 617
Parkinson’s Disease: From Pathogenesis to Pharmacogenomics
Cacabelos, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030551 · Cited by 588
Dark microglia: A new phenotype predominantly associated with pathological states
Bisht, K., Sharma, K. P., Lecours, C., Gabriela Sánchez, M., El Hajj, H., Milior, G., Olmos‐Alonso, A., Gómez‐Nicola, D., Luheshi, G., Vallières, L., et al. (2016) · Glia · doi:10.1002/glia.22966 · Cited by 421
Influence of gut microbiota on neuropsychiatric disorders
Cénit, M. C., Sanz, Y., & Codoñer‐Franch, P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i30.5486 · Cited by 433
DNA Methylation Biomarkers in Aging and Age-Related Diseases
Salameh, Y., Bejaoui, Y., & Hajj, N. E. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00171 · Cited by 322
Aging and Alzheimer's disease: comparison and associations from molecular to system level
Xia, X., Jiang, Q., McDermott, J., & Han, J. J. (2018) · Aging Cell · doi:10.1111/acel.12802 · Cited by 301
Monoaminergic neuropathology in Alzheimer’s disease
Šimić, G., Leko, M. B., Wray, S., Harrington, C. R., Delalle, I., Milošević, N. J., Bažadona, D., Buée, L., de Silva, R., Giovanni, G. D., et al. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.001 · Cited by 297
Self-citationCai, W., Zhang, K., Li, P., Zhu, L., Xu, J., Yang, B., Hu, X., Lu, Z., & Chen, J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.006 · Cited by 296
Klein, H., Aubin, C., Gjoneska, E., Sullivan, S. E., Kaskow, B. J., Tang, A. Y., Smith, R. V., Xu, J., Pfenning, A. R., Bernstein, B., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0291-1 · Cited by 283
Lymphatic drainage system of the brain: A novel target for intervention of neurological diseases
Sun, B., Wang, L.-H., Yang, T., Sun, J., Mao, L., Yang, M., Yuan, H., Colvin, R. A., & Yang, X. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.007 · Cited by 264
Cattaneo, A., Cattane, N., Begni, V, Pariante, C. M., & Riva, M. A. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.214 · Cited by 244
Galanter, J., Gignoux, C. R., Oh, S. S., Torgerson, D., Pino-Yanes, M. D. M., Thakur, N., Eng, C. S., Hu, D., Huntsman, S., Farber, H. J., et al. (2017) · eLife · doi:10.7554/elife.20532 · Cited by 238
Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration
Neal, M. P., & Richardson, J. R. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.11.004 · Cited by 195
Noncoding RNAs in neurodegeneration
Salta, E., & De Strooper, B. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.90 · Cited by 183
Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease
Zheng, Y., Liu, A., Wang, Z.-J., Cao, Q., Wang, W., Lin, L., Ma, K., Zhang, F., Wei, J., Matas, E., et al. (2019) · Brain · doi:10.1093/brain/awy354 · Cited by 168
Herbert, J., & Lucassen, P. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.12.001 · Cited by 150
Millan, M. J. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.004 · Cited by 151
Genetic and epigenetic regulation of human aging and longevity
Morris, B. J., Willcox, B. J., & Donlon, T. A. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.039 · Cited by 140
Delgado‐Morales, R., Agís‐Balboa, R. C., Esteller, M., & Berdasco, M. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0365-z · Cited by 147
The Epigenetics of Alzheimer’s Disease: Factors and Therapeutic Implications
Liu, X., Jiao, B., & Shen, L. H. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00579 · Cited by 153
Epigenetics of Aging and Alzheimer’s Disease: Implications for Pharmacogenomics and Drug Response
Cacabelos, R., & Torrellas, C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226236 · Cited by 144
The Role of Epigenetics in Genetic and Environmental Epidemiology
Ladd‐Acosta, C., & Fallin, M. D. (2015) · Epigenomics · doi:10.2217/epi.15.102 · Cited by 148
Wang, S., Yang, F., Petyuk, V., Shukla, A. K., Monroe, M. E., Gritsenko, M. A., Rodland, K., Smith, R. D., Qian, W., Gong, C., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4929 · Cited by 134
Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood
Lardenoije, R., Roubroeks, J. A. Y., Pishva, E., Leber, M., Wagner, H., Iatrou, A., Smith, A. R., Smith, R. G., Eijssen, L., Kleineidam, L., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0755-5 · Cited by 135
Self-citationCytosine-Based TET Enzyme Inhibitors
Chua, G. N. L., Wassarman, K. L., Sun, H., Alp, J. A., Jarczyk, E. I., Kuzio, N. J., Bennett, M. J., Malachowsky, B. G., Kruse, M., & Kennedy, A. J. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00474 · Cited by 135
Downregulation of blood serum microRNA 29 family in patients with Parkinson’s disease
Bai, X., Tang, Y., Yu, M., Wu, L., Liu, F., Ni, J., Wang, Z., Wang, J., Fei, J., Wang, W., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03887-3 · Cited by 124
Cohen, R. A., Marsiske, M., & Smith, G. E. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00010-8 · Cited by 150
Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease
Nordestgaard, L. T., Christoffersen, M., & Frikke‐Schmidt, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179777 · Cited by 128
Wen, K., Milić, J., El‐Khodor, B. F., Dhana, K., Nano, J., Pulido, T., Kraja, B., Začiragić, A., Bramer, W. M., Troup, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167201 · Cited by 130
Meng, Q., Zhuang, Y., Ying, Z., Agrawal, R., Yang, X., & Gómez‐Pinilla, F. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.046 · Cited by 117
α-Synuclein in Parkinson’s disease: causal or bystander?
Riederer, P. F., Berg, D., Casadei, N., Cheng, F., Claßen, J., Dresel, C., Jost, W. H., Krüger, R., Müller, T. H., Reichmann, H., et al. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02025-9 · Cited by 122
Milk’s Role as an Epigenetic Regulator in Health and Disease
Melnik, B. C., & Schmitz, G. (2017) · Diseases · doi:10.3390/diseases5010012 · Cited by 117
Epigenetics and obesity cardiomyopathy: From pathophysiology to prevention and management
Zhang, Y., & Ren, J. T. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.005 · Cited by 109
Cao, Q., Wang, W., Williams, J. B., Yang, F., Wang, Z.-J., & Yan, Z. (2020) · Science Advances · doi:10.1126/sciadv.abc8096 · Cited by 108
Mitophagy plays a central role in mitochondrial ageing
Diot, A., Morten, K., & Poulton, J. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9651-x · Cited by 112
DNA methylation in Parkinson's disease
Wüllner, U., Kaut, O., deBoni, L., Piston, D., & Schmitt, I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13646 · Cited by 107
The Exceptional Vulnerability of Humans to Alzheimer’s Disease
Walker, L. C., & Jucker, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.04.001 · Cited by 108
Scheff, S. W., Ansari, M. A., & Mufson, E. J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.030 · Cited by 100
Classifying aging as a disease in the context of ICD-11
Zhavoronkov, A. A., & Bhullar, B. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00326 · Cited by 103
Astrocytic ceramide as possible indicator of neuroinflammation
de Wit, N. M., den Hoedt, S., Martínez‐Martínez, P., Rozemüller, A. J. M., Mulder, M. T., & de Vries, H. E. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1436-1 · Cited by 100
The glymphatic system and meningeal lymphatics of the brain: new understanding of brain clearance
Yankova, G., Bogomyakova, O. B., & Тулупов, А. А. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0106 · Cited by 110
Histone Methylation Regulation in Neurodegenerative Disorders
Basavarajappa, B. S., & Subbanna, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094654 · Cited by 103
Pan, L., Cho, K., Yi, I., To, C. H., Chen, D. F., & Wai, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8377362 · Cited by 100
Role of Histone Post-Translational Modifications in Inflammatory Diseases
Lin, Y., Qiu, T., Wei, G., Que, Y., Wang, W., Kong, Y., Xie, T., & Chen, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.852272 · Cited by 96
Epigenetic impacts of endocrine disruptors in the brain
Walker, D. M., & Gore, A. C. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.09.002 · Cited by 94
Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases
de Souza, J. M., Gonçalves, B. D. C., Gomez, M. V., Vieira, L. B., & Ribeiro, F. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00145 · Cited by 94
Pellegrini, C., Pirazzini, C., Sala, C., Sambati, L., Yusipov, I., Kalyakulina, A., Ravaioli, F., Kwiatkowska, K. M., Durso, D. F., Ivanchenko, M., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.639428 · Cited by 90
Epigenetics and Regulation of Oxidative Stress in Diabetic Retinopathy
Duraisamy, A. J., Mishra, M., Kowluru, A., & Kowluru, R. A. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24548 · Cited by 91
Ren, F., Wei, J., Chen, Q., Hu, M., Yu, L., Mi, J., Zhou, X., Qin, D., Wu, J., & Wu, A. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.030 · Cited by 97
Epigenetic drug discovery for Alzheimer’s disease
Cacabelos, R., & Torrellas, C. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.930124 · Cited by 88
DNA Methylation and Adult Neurogenesis
Jobe, E. M., & Zhao, X. (2016) · Brain Plasticity · doi:10.3233/bpl-160034 · Cited by 85
Epigenetics in Parkinson’s Disease
Pavlou, M. A. S., & Outeiro, T. F. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_19 · Cited by 85
Traumatic Brain Injury Alters Methionine Metabolism: Implications for Pathophysiology
Dash, P. K., Hergenroeder, G. W., Jeter, C. B., Choi, H. A., Kobori, N., & Moore, A. N. (2016) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2016.00036 · Cited by 81
Gut–Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders
Toledo, A. R. L., Monroy, G. R., Salazar, F. E., Lee, J.-Y., Jain, S., Yadav, H., & Borlongan, C. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031184 · Cited by 83
Park, H., Shin, J., Kim, Y.-K., Saito, T., Saido, T. C., & Kim, J. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00314-0 · Cited by 87
Epigenetic mechanisms related to cognitive decline during aging
Harman, M. F., & Martín, M. G. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24436 · Cited by 83
Opening up the DNA methylome of dementia
Delgado‐Morales, R., & Esteller, M. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.242 · Cited by 74
CRISPR-Based Epigenome Editing: Mechanisms and Applications
Fadul, S. M., Arshad, A., & Mehmood, R. (2023) · Epigenomics · doi:10.2217/epi-2023-0281 · Cited by 86
Sexually divergent DNA methylation patterns with hippocampal aging
Masser, D. R., Hadad, N., Porter, H. L., Mangold, C. A., Unnikrishnan, A., Ford, M. M., Giles, C. B., Georgescu, C., Dozmorov, M. G., Wren, J. D., et al. (2017) · Aging Cell · doi:10.1111/acel.12681 · Cited by 70
Chouliaras, L., Pishva, E., Haapakoski, R., Zsoldos, E., Mahmood, A., Filippini, N., Burrage, J., Mill, J. S., Mika Kivimaki, B., Lunnon, K., et al. (2018) · Epigenomics · doi:10.2217/epi-2017-0132 · Cited by 70
Chemo brain: From discerning mechanisms to lifting the brain fog—An aging connection
Kovalchuk, A., & Kolb, B. E. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1334022 · Cited by 69
Shedding Light on the Dark Side of the Microglia
St‐Pierre, M., Šimončičová, E., Bögi, E., & Tremblay, M. (2020) · ASN NEURO · doi:10.1177/1759091420925335 · Cited by 66
Dysregulation of C-X-C motif ligand 10 during aging and association with cognitive performance
Bradburn, S., McPhee, J. S., Bagley, L., Carroll, M. A., SLEVIN, M. A., Al‐Shanti, N., Barnouin, Y., Hogrel, J., Pääsuke, M., Gapeyeva, H., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.11.009 · Cited by 66
Teijido, Ó., & Cacabelos, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103199 · Cited by 69
Monti, N., Cavallaro, R. A., Stoccoro, A., Nicolia, V., Scarpa, S., Kovács, G. G., Fiorenza, M. T., Lucarelli, M., Aronica, E., Ferrer, I., et al. (2020) · Epigenetics · doi:10.1080/15592294.2020.1722917 · Cited by 72
Ianov, L., Riva, A., Kumar, A., & Foster, T. C. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00249 · Cited by 65
Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases
Walker, L. C. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-120215-034943 · Cited by 60
Molecular Biomarkers in Neurological Diseases: Advances in Diagnosis and Prognosis
Myrou, A. D., Barmpagiannos, K., Ioakimidou, A., & Savopoulos, C. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052231 · Cited by 66
Dietary Phytochemicals in Neuroimmunoaging: A New Therapeutic Possibility for Humans?
Corbi, G., Conti, V., Davinelli, S., Scapagnini, G., Filippelli, A., & Ferrara, N. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00364 · Cited by 63
Corley, J., Cox, S. R., Harris, S. E., Hernandez, M. V., Maniega, S. M., Bastin, M. E., Wardlaw, J. M., Starr, J. M., Marioni, R. E., & Deary, I. J. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0576-5 · Cited by 64
Promising landscape for regulating macrophage polarization: epigenetic viewpoint
Zhou, D., Yang, K., Chen, L., Zhang, W., Xu, Z., Zuo, J., Jiang, H., & Luan, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17027 · Cited by 64
Entanglement of Genetics and Epigenetics in Parkinson’s Disease
van Heesbeen, H. J., & Smidt, M. P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00277 · Cited by 60
Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis
Citraro, R., Leo, A., Santoro, M., D’Agostino, G., Constanti, A., & Russo, E. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612823666171024130001 · Cited by 58
Epigenetic signatures of methylated DNA cytosine in Alzheimer’s disease
Fetahu, I. S., Ma, D., Rabidou, K., Argueta, C. E., Smith, M., Liu, H., Wu, F., & Shi, Y. G. (2019) · Science Advances · doi:10.1126/sciadv.aaw2880 · Cited by 60
Early Life Nutrition and Mental Health: The Role of DNA Methylation
Bekdash, R. A. (2021) · Nutrients · doi:10.3390/nu13093111 · Cited by 56
Bai, N., Li, N., Cheng, R., Guan, Y., Zhao, X., Song, Z., Xu, H., Yi, F., Jiang, B., Li, X., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111062 · Cited by 59
Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology
Guo, J., Cheng, J., North, B. J., & Wei, W. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.07.001 · Cited by 55
Wei, Z., Meng, X., Fatimy, R. E., Sun, B., Mai, D., Zhang, J., Arora, R., Zeng, A., Xu, P., Qu, S., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104617 · Cited by 59
Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity
Pan, Y., Daito, T., Sasaki, Y., Chung, Y. H., Xing, X., Pondugula, S., Swamidass, S. J., Wang, T., Kim, A. H., & Yano, H. (2016) · Scientific Reports · doi:10.1038/srep31022 · Cited by 51
Wu, Y., Hou, F., Wang, X., Kong, Q., Han, X., & Bai, B. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00114 · Cited by 52
Kernaleguen, M., Daviaud, C., Shen, Y., Bonnet, É., Renault, V., Deleuze, J., Mauger, F., & Tost, J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7774-1_18 · Cited by 53
Yu, L., Chibnik, L. B., Yang, J., Aubin, C., Xu, J., Schneider, J. A., Jager, P. L. D., & Bennett, D. A. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.02.009 · Cited by 51
Chatterjee, P., Roy, D., Bhattacharyya, M., & Bandyopadhyay, S. (2017) · BMC Genomics · doi:10.1186/s12864-017-4098-3 · Cited by 53
Dinicola, S., Proietti, S., Cucina, A., Bizzarri, M., & Fuso, A. (2017) · Antioxidants · doi:10.3390/antiox6040074 · Cited by 50
Epigenetic small molecule modulators of histone and DNA methylation
Hauser, A., Robaa, D., & Jung, M. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.03.003 · Cited by 50
Bacon, E. R., & Brinton, R. D. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.040 · Cited by 52
Griñán‐Ferré, C., Bellver‐Sanchís, A., Guerrero, A. T. G., & Pallàs, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107247 · Cited by 55
Hadad, N., Masser, D. R., Logan, S., Wronowski, B., Mangold, C. A., Clark, N. W., Otalora, L., Unnikrishnan, A., Ford, M. M., Giles, C. B., et al. (2016) · Epigenetics & Chromatin · doi:10.1186/s13072-016-0080-6 · Cited by 48
Klein, H.-U., Bennett, D. A., & De Jager, P. L. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1612-7 · Cited by 49
Cai, M., Zhang, W., Weng, Z., Stetler, R. A., Jiang, X., Shi, Y., Gao, Y., & Chen, J. (2017) · Aging and Disease · doi:10.14336/ad.2017.0520 · Cited by 49
Emerging Roles of Meningeal Lymphatic Vessels in Alzheimer’s Disease
Guo, X., Zhang, G., Peng, Q., Huang, L., Zhang, Z., & Zhang, Z. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221016 · Cited by 49
HDAC4 in ischemic stroke: mechanisms and therapeutic potential
Kong, Q., Hao, Y., Li, X., Wang, X., Ji, B., & Wu, Y. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0549-1 · Cited by 47
Zhu, X., Lan, B., Yi, X., He, C., Dang, L., Zhou, X., Lu, Y., Sun, Y., Liu, Z., Bai, X., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa441 · Cited by 43
Roles of physical exercise in neurodegeneration: reversal of epigenetic clock
Xu, M., Zhu, J., Liu, X.-D., Luo, M.-Y., & Xu, N.-J. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00254-1 · Cited by 46
Devall, M. A. M., Roubroeks, J. A. Y., Mill, J. S., Weedon, M. N., & Lunnon, K. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.013 · Cited by 46
Metadata
- Authors
- Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., & Rutten, B. P. F.
- Affiliations
- Maastricht University (NL)
- University of Lausanne (CH)
- Banner Sun Health Research Institute (US)
- Brigham and Women's Hospital (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Rutten, Bart P.F.
- ORCID
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 131
- Pages
- 21-64
- ISSN
- 0301-0082 (ISSN-L)
- PMC
- PMC6477921
- OpenAlex
- W648684004
- Cited by
- 381
- References
- 770
- Citations by year
- 2026: 12 · 2025: 29 · 2024: 28 · 2023: 28 · 2022: 32 · 2021: 47 · 2020: 30 · 2019: 42 · 2018: 39 · 2017: 43 · 2016: 38 · 2015: 11
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Progress in Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- Internationale Stichting Alzheimer Onderzoek (07551, 11532, 09552, 13515)
- Netherlands Organization for Scientific Research (916.11.086)
- National Institutes of Health (P50 AG005138)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- epigenetics, aging, neurodegeneration, DNA methylation, DNA demethylation, chromatin remodeling, non-coding RNA, Alzheimer's disease, Parkinson's disease, Huntington's disease, epigenetic therapy, gene expression regulation, histone modifications
- MeSH terms
- Aging, Animals, Humans, DNA Methylation, Neurodegenerative Diseases, Genetic Predisposition to Disease, RNA, Untranslated, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review